Is it cost-effective to request IgM oligoclonal bands against lipids in daily practice as a biomarker for poor prognosis in multiple sclerosis?
Mult Scler Relat Disord
; 79: 105033, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-37832257
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Multiple Sclerosis
Limits:
Humans
Language:
En
Journal:
Mult Scler Relat Disord
Year:
2023
Document type:
Article
Country of publication:
Países Bajos